Cover Image
Market Research Report
Product code 
1086349

Pharmacovigilance Global Market Report 2022

Published: Pre-Order | The Business Research Company | 175 Pages | Delivery time: 2-10 business days

Price

Back to Top
Pharmacovigilance Global Market Report 2022
Published: Pre-Order
The Business Research Company
Content info: 175 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents

“Pharmacovigilance Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global pharmacovigilance market.

This report focuses on pharmacovigilance market which is experiencing strong growth. The report gives a guide to the pharmacovigilance market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the pharmacovigilance market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Pharmacovigilance Market global report” from The Business Research Company answers all these questions and many more. The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmacovigilance market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The pharmacovigilance market section of the report gives context. It compares the pharmacovigilance market with other segments of the pharmacovigilance market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, pharmacovigilance market indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Spontaneous Reporting; Intensified ADR Reporting; Targeted Spontaneous Reporting; Cohort Event Monitoring; EHR Mining
  • 2) By Service Provider: In-House; Contract Outsourcing
  • 3) By Process Flow: Case Data Management; Signal Detection; Risk Management System
  • 4) By Clinical Trial Phases: Preclinical; Phase I; Phase II; Phase III; Phase IV
  • 5) By End User: Hospitals; Pharmaceutical Companies; Other End Users
  • Companies Mentioned: Accenture; Cognizant; Labcorp Drug Development; IQVIA; Parexel International Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary

Major players in the pharmacovigilance market are: Accenture, Cognizant, Labcorp Drug Development, IQVIA, IQVIA, Parexel International Corporation, BioClinica Inc., Clinquest Inc., ITClinical, TAKE Solutions Limited, United BioSource LLC, Wipro Limited, Bristol-Myers Squibb Company, Linical Americas, iMEDGlobal, Boehringer Ingelheim International GmbH, Novartis AG, Ecron Acunova Limited, and Sanofi.

The global pharmacovigilance market is expected to grow from $5.71 billion in 2021 to $6.64 billion in 2022 at a compound annual growth rate (CAGR) of 16.2%. The pharmacovigilance market is expected to reach $10.57 billion in 2026 at a CAGR of 12.3%.

The pharmacovigilance market consists of sales of pharmacovigilance services by entities (organizations, sole traders, and partnerships) that collect, assess, and distribute drug safety and efficiency data. Pharmacovigilance is the science and practice of monitoring approved pharmaceuticals and experimental products prior to their approval for use in order to discover, evaluate, assess, and avoid adverse drug and vaccination effects and problems.

The main types of pharmacovigilance are spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and EHR mining. Spontaneous reporting is by nature a passive approach to pharmacovigilance relying entirely on the motivation of individuals to report suspected adverse drug reactions to local or national pharmacovigilance centers. The different process flows include case data management, signal detection, and risk management system. The various services providers are in-house and contract to outsource and involve several clinical trial phases such as preclinical, phase I, phase II, phase II, and phase IV. These services are used by several end-users including hospitals pharmaceutical companies and others.

North America was the largest region in the pharmacovigilance market in 2021. Asia Pacific is expected to be the fastest growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The growing incidences of adverse drug reactions are expected to propel the growth of the pharmacovigilance market going forward. An adverse drug reaction is defined as a harmful, unpleasant, or dangerous reaction resulting from the use of any medicinal product. Pharmacovigilance personnel is primarily responsible for monitoring adverse drug reactions (ADRs) in order to ensure safe drug usage and ensure drug safety prior to approval for public use. For instance, according to United Nations Office on Drugs and Crime (UNODC) World Drug Report published in 2021, approximately 36 million persons worldwide suffered from drug use disorders in 2020, out of 275 million drug users. Therefore, the growing incidence of adverse drug reactions is promoting the growth of the pharmacovigilance market.

Technological advancements have emerged as a key trend gaining popularity in the pharmacovigilance market. Many companies operating in the pharmacovigilance sector are adopting advanced technological solutions such as Artificial intelligence (AI) to reduce cycle time, enriched quality and accuracy, scalable and futuristic solutions, improved productivity, and better compliance. For instance, in December 2019, UCB, a Belgium-based biopharmaceutical company, and Accenture, an Ireland-based professional services company collaborated to develop a patient safety solution based on Accenture's INTIENT Pharmacovigilance technology platform. This solution will use real-time artificial intelligence (AI), robotic process automation, and machine learning automation in the data management process, from acquiring patient information and inputs to regulatory reporting.

In January 2020, Ergomed Plc., a UK-based pharmaceutical industry service provider acquired Ashfield Pharmacovigilance Inc. for $10 million. With this acquisition, Ergomed Plc will strengthen Ergomed CRO business in the US market and will become a global leader in pharmaceutical services specialists. Ashfield Pharmacovigilance Inc. is a US-based company that provides pharmacovigilance services.

The countries covered in the pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Product Code: h1600

Table of Contents

1. Executive Summary

2. Pharmacovigilance Market Characteristics

3. Pharmacovigilance Market Trends And Strategies

4. Impact Of COVID-19 On Pharmacovigilance

5. Pharmacovigilance Market Size And Growth

  • 5.1. Global Pharmacovigilance Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Pharmacovigilance Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Pharmacovigilance Market Segmentation

  • 6.1. Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining
  • 6.2. Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • In-House
  • Contract Outsourcing
  • 6.3. Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Case Data Management
  • Signal Detection
  • Risk Management System
  • 6.4. Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • 6.5. Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Pharmaceutical Companies
  • Other End Users

7. Pharmacovigilance Market Regional And Country Analysis

  • 7.1. Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Pharmacovigilance Market

  • 8.1. Asia-Pacific Pharmacovigilance Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Pharmacovigilance Market

  • 9.1. China Pharmacovigilance Market Overview
  • 9.2. China Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Pharmacovigilance Market

  • 10.1. India Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Pharmacovigilance Market

  • 11.1. Japan Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Pharmacovigilance Market

  • 12.1. Australia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Pharmacovigilance Market

  • 13.1. Indonesia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Pharmacovigilance Market

  • 14.1. South Korea Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Pharmacovigilance Market

  • 15.1. Western Europe Pharmacovigilance Market Overview
  • 15.2. Western Europe Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Pharmacovigilance Market

  • 16.1. UK Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Pharmacovigilance Market

  • 17.1. Germany Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Pharmacovigilance Market

  • 18.4. France Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Pharmacovigilance Market

  • 19.1. Eastern Europe Pharmacovigilance Market Overview
  • 19.2. Eastern Europe Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Pharmacovigilance Market

  • 20.1. Russia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Pharmacovigilance Market

  • 21.1. North America Pharmacovigilance Market Overview
  • 21.2. North America Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Pharmacovigilance Market

  • 22.1. USA Pharmacovigilance Market Overview
  • 22.2. USA Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Pharmacovigilance Market

  • 23.1. South America Pharmacovigilance Market Overview
  • 23.2. South America Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Pharmacovigilance Market

  • 24.1. Brazil Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Pharmacovigilance Market

  • 25.1. Middle East Pharmacovigilance Market Overview
  • 25.2. Middle East Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Pharmacovigilance Market

  • 26.1. Africa Pharmacovigilance Market Overview
  • 26.2. Africa Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Pharmacovigilance Market Competitive Landscape And Company Profiles

  • 27.1. Pharmacovigilance Market Competitive Landscape
  • 27.2. Pharmacovigilance Market Company Profiles
    • 27.2.1. Accenture
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Cognizant
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Labcorp Drug Development
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. IQVIA
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Parexel International Corporation
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Pharmacovigilance Market

29. Pharmacovigilance Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer